Dovre will realize significant value through the announced sale, which should help it to better find...
An acquisition that opens the door for further expansion globally.
Nettoomsättningen var i linje med föregående år och är fortsatt påverkat av de längre säljcyklerna.
Redeyes’ long-term view of Dignitana continues to be positive.
Redeye leaves a research update following Klaria Pharma’s recently published Q3 2024 report.
Redeye was negatively surprised by the lower-than-expected sales in the quarter.
Umida är en företags- och varumärkesgrupp som utvecklar, marknadsför och säljer drycker med och utan...
The report was overall better than expected and the main deviation comes from a slower itegration of...
First Venture publicerade den 21 november 2024 bolagets delårsrapport för det tredje kvartalet av 20...
Redeye comments on Enviro’s Q3 report, which reported positive earnings for a third consecutive quar...
Automations- och säkerhetsbolaget Kentima levererade ett starkt kvartal trots en svag marknad.
Redeye comments on Jumpgates Q3 results, which was in line with our forecasts regarding sales and ma...
Beyond Frames reported net sales that were 8% lower than Redeye's estimate.
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) meddelade den 20 november år 20...
Q3 weak but it's a small quarter for '24e Estimates for Pome divestment pushed to '25e from '24e Sal...
Redeye updates its view on Flexion Mobile following its Q3 2024 report, which was largely in line wi...
Största ägaren Symrise lägger ett bud om 350 kronor per aktie i syfte att förvärva hela bolaget.
Redeye comments on Ngenic’s announcement of a SEK34m rights issue of units consisting of shares and ...
Redeye comments on the outcome of Iconovo’s rights issue.
Luxbright (”Luxbright” eller ”Bolaget”) fortsätter att uppvisa starkt momentum med flera framgångar ...
